Stay updated on Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.
Latest updates to the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded related topic MedlinePlus Genetics and updated location references (Florida); the page revision was updated to v3.3.3 and HHS Vulnerability Disclosure and Florida Locations were removed.SummaryDifference0.4%
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page, an internal versioning change that does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check40 days agoChange DetectedRemoved the generic government funding/operating status notice from the page; it does not affect study details or access. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check62 days agoChange DetectedMelanoma and related MedlinePlus Genetics topics were removed from the page.SummaryDifference0.7%
- Check76 days agoChange DetectedAdded new MedlinePlus Genetics topic: Melanoma. No deletions.SummaryDifference0.2%
- Check83 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%
Stay in the know with updates to Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.